Altogether, our data demonstrated how disrupted metabolism caused by FH deficiency can lead to unique metabolic traits that produce stable circulating metabolites that can serve as sensitive and specific biomarkers for the early diagnosis and prognostication of FH-MT RCC. The gene discussed is FH; the disease is hyperinsulinemic hypoglycemia, familial, 4.